O
33
-4
SRE
52
2
RSG
62
2
TGNA
37
-3
JNPR
59
3
AKAM
54
3
IPG
50
2
UPS
28
3
BA
48
-5
HAS
37
4
OMC
62
3
L
51
5
EMC
71
9
BXP
49
2
VLO
33
3
PYPL
41
2
QRVO
4
2
AAPL
39
-3
AVY
53
3
FOXA
63
3
O
33
-4
SRE
52
2
RSG
62
2
TGNA
37
-3
JNPR
59
3
AKAM
54
3
IPG
50
2
UPS
28
3
BA
48
-5
HAS
37
4
OMC
62
3
L
51
5
EMC
71
9
BXP
49
2
VLO
33
3
PYPL
41
2
QRVO
4
2
AAPL
39
-3
AVY
53
3
FOXA
63
3
Financhill
Back

Genmab AS Vs. Novo Nordisk AS Industry Stock Comparison

Sell
29

GMAB
Genmab AS

Last Price:
22.07
Seasonality Move:
4.61%
Sell
36

NVO
Novo Nordisk AS

Last Price:
108.55
Seasonality Move:
7.98%
Sell
29
Genmab AS (GMAB) is a Sell

Is Genmab AS a Buy, Sell or Hold?

  • The current Genmab AS [GMAB] share price is $22.75. The Score for GMAB is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • GMAB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $110.13. The Score for NVO is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GMAB Stock Price Chart

What is Genmab AS's stock price today?

  • The Genmab AS share price today is $22.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GMAB is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $110.13
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.

GMAB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.51 Sell
Relative Strength Index (14 RSI): 38.46 Sell
Chaikin Money Flow: 1189998 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.68 - 23.5) Sell
Bollinger Bands (100): (23.86 - 27.54) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.43 Sell
Relative Strength Index (14 RSI): 28.5 Sell
Chaikin Money Flow: 5524545 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (112.57 - 118.31) Sell
Bollinger Bands (100): (119.81 - 140.01) Sell

GMAB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.79 Sell
20-day SMA: 22.99 Sell
50-day SMA: 24.68 Sell
200-day SMA: 27.29 Sell
8-day EMA: 22.75 Sell
20-day EMA: 23.1 Sell
50-day EMA: 24.24 Sell
200-day EMA: 27.4 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.84 Sell
20-day SMA: 115.18 Sell
50-day SMA: 123.49 Sell
200-day SMA: 128.24 Sell
8-day EMA: 111.96 Sell
20-day EMA: 114.98 Sell
50-day EMA: 121.01 Sell
200-day EMA: 122.69 Sell

Genmab AS Earnings Growth & GMAB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $0.33 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.87 per share.

Genmab AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):